ACRX Overview
Upcoming Projects (ACRX)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (ACRX)
-
Digging into the details of AcelRx's 1.1bn peak sales claim for ARX-04
Tickers: ACRX, REPH
Execute By: Jan 27, 2017
Upcoming & Overdue Catalysts (ACRX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ACRX)
-
The Prescription Drug User Fee Act (PDUFA) date for DSUVIA in Moderate-To-Severe Acute Pain Management set for November 3, 2018
Ticker: ACRX
Occurred on: Nov 02, 2018 -
PDUFA Date of October 12th for AcelRx's (ACRX) ARX-04 (DSUVIA) New Drug Application in Moderate-to-Severe Pain
Ticker: ACRX
Occurred on: Oct 12, 2017 -
Phase 3 study of Zalviso in patients with post-operative pain expected to complete August 2017
Ticker: ACRX
Occurred on: Aug 07, 2017 -
NDA of ARX-04 (sufentanil sublingual tablet 30mcg) for Moderate-to-severe acute pain to be filed 2H 2016
Ticker: ACRX
Occurred on: Dec 13, 2016 -
AcelRx Pharmaceuticals Reports on ARX-04 Market and Landscape Presented at Analyst & Investor Event
Ticker: ACRX
Occurred on: Dec 06, 2016 -
AcelRx Pharmaceuticals Unveiling Results of ARX-04 SAP303 Study in Post-Operative Setting at the Annual ASRA Pain Medicine Meeting
Ticker: ACRX
Occurred on: Nov 17, 2016 -
AcelRx (ACRX) Pharmaceuticals Presenting ARX-04 Clinical Trial Findings and Cost Analysis at European Congress on Emergency Medicine
Ticker: ACRX
Occurred on: Sep 28, 2016 -
AcelRx (ACRX) Initiates Phase 3 Study of Zalviso in Patients with Moderate-to-Severe Acute Post-Operative Pain
Ticker: ACRX
Occurred on: Sep 27, 2016 -
AcelRx (ACRX) Announces Phase III Results for ARX-04 in Treatment of Moderate-to-Severe Acute Pain
Ticker: ACRX
Occurred on: Sep 15, 2016 -
AcelRx Publishes a Review of Hospital-Based Opioid Patient-Controlled Analgesia, Risks and Pharmacoeconomics
Ticker: ACRX
Occurred on: Mar 25, 2016 -
AcelRx Pharmaceuticals Advances ARX-04 into Extension Phase of Open-Label Phase 3 Emergency Room Study
Ticker: ACRX
Occurred on: Mar 14, 2016 -
AcelRx Pharmaceuticals Initiates Phase 3 Study of ARX-04 in Patients with Post-Operative Moderate-to-Severe Acute Pain
Ticker: ACRX
Occurred on: Mar 07, 2016
Strategic Initiatives (ACRX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
